Skip to primary content

The Jacobson Laboratory at UCSF

Computational structural biology, biophysics, and drug design

The Jacobson Laboratory at UCSF

Main menu

  • Welcome!
  • Biosketch
  • Research
  • Publications
  • Group
  • Companies
  • Resources
  • Teaching
  • Contact

Post navigation

← Previous Next →

151.

Posted on October 21, 2016 by jacobson66

M. Armstrong, C. van Hoorebeke, T. Horn, J. Deschamps, J. C. Freedman, C. Kalyanaraman, M. P. Jacobson, and T. Holman.  “Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency”, Bioorg. Med. Chem., 24 (2016) 5380-5387.  PMC5065787

This entry was posted in Computer-Aided Drug Design and tagged Docking by jacobson66. Bookmark the permalink.
Blog at WordPress.com.
  • Follow Following
    • The Jacobson Laboratory at UCSF
    • Already have a WordPress.com account? Log in now.
    • The Jacobson Laboratory at UCSF
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar